MedTrace Logo

Optimizing Clinical Outcomes in HIV-Infected Adults & Children

NCT02043080 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1436

Last updated 2017-08-03

No results posted yet for this study

Summary

This is a study to evaluate Xpert MTB/RIF as the first-line TB diagnostic test in HIV-infected adults and pediatric patients as a means to obtain faster, more accurate TB diagnosis.

Conditions

  • Tuberculosis Diagnosis
  • HIV

Interventions

OTHER

Xpert MTB/RIF Tuberculosis diagnostic tool

This is s new diagnostic tool that has been approved by WHO for the diagnosis of TB in HIV-infected patients in resource limited settings

Sponsors & Collaborators

Principal Investigators

  • Stewart Reid, MD · University of North Carolina

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2016-03-31
Completion
2017-04-30

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02043080 on ClinicalTrials.gov